Industry

Life Sciences and Health Care

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires a partner with a holistic, collaborative approach and a global perspective. It calls for a strategy informed by asking the right questions and rooted in identifying creative solutions to...

Boston Compliance Forum

Join the Hogan Lovells Boston team along with regional and international colleagues for an informative breakfast forum in Cambridge, MA. The forum features two sessions that explore a range ...

Quick view Full view

Hogan Lovells Publications

A bit more Sunshine: CMS proposes collecting additional information on manufacturer payments under the Open Payments program Health Alert

Device and drug manufacturers got a small surprise in the annual Physician Fee Schedule proposed rule (at 40,713-16) issued late in July by the Centers for Medicare & Medicaid Services...

Quick view Full view

Hogan Lovells Publications

Proposed additions of chemical families to Schedule 1 of Chemical Weapons Convention and BIS requests for comments from chemical, biotechnology and pharmaceutical companies International Trade Alert

On 14 August 2019 the U.S. Department of Commerce published a proposed change to the list of "Schedule 1" chemicals in the "Annex on Chemicals" to the Chemical Weapons Convention (CWC).

Quick view Full view

Press Releases

Hogan Lovells advised Jazz Pharmaceuticals on its acquisition of Cavion

Silicon Valley, 12 August 2019– International Law firm Hogan Lovells represented global biopharmaceutical company Jazz Pharmaceuticals, plc in the acquisition of Cavion, Inc. through a...

Quick view Full view

Hogan Lovells Publications

New draft guidance on MR compatibility for medical devices Medical Device Alert

The U.S. Food and Drug Administration (FDA) has published a new draft guidance titled "Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment."

Quick view Full view

Hogan Lovells Publications

Online sale of pharmaceuticals in Russia remains prohibited and lawmakers are yet to pass the bill allowing online sales

Russian law currently prohibits the online sale of pharmaceuticals and requires that pharmaceuticals must be sold only in stationary pharmacies operated by a person holding a pharmaceutical ...

Quick view Full view
Loading data